Challenge An antidote not registered in Italy but used regularly by hospitals on an unlicensed basis, due to lack of domestic product, was facing a worldwide shortage. As such, hospitals across the country could no [...]

Challenge An oral solution used for radiological investigational purposes was facing a nation-wide shortage in the UK, due to issues with the Active Pharmaceutical Ingredient (API). Hospitals across the country needed this product urgently and [...]

Challenge An oncology product was in short supply all over Europe and hospitals in Spain were running out of stock. This was an important, first-line treatment, that was needed in large quantities for cancer patients. [...]

Challenge It is not uncommon for a physician to come across a patient who, for whatever reason, cannot receive the conventional treatment for their pathology. It may be due to age, physical limitations, allergies to [...]

Challenge An important oncology product was facing a nation-wide shortage in the UK which was lasting longer than expected, as the QA-release of the UK-licensed stock was being continuously postponed. There are currently no alternative [...]

Challenge Italian hospitals were facing a nation-wide shortage of an important vaccine used to treat critical patients. There were no alternative treatment options available in the country and even the national medicines agency, AIFA, was [...]